ARCA biopharma Inc

NASDAQ:ABIO   3:59:40 PM EDT
4.04
-0.06 (-1.46%)
Products

Arca Biopharma Announces FDA Approval Of IND Application For Ab201 As A Potential Treatment For Covid-19

Published: 10/07/2020 12:47 GMT
ARCA Biopharma Inc (ABIO) - Arca Biopharma Announces FDA Approval of Ind Application for Ab201 As a Potential Treatment for Covid-19.
Arca Biopharma Inc - Initiation of Phase 2b Clinical Trial Anticipated in Q4 2020.
Arca Biopharma Inc - Trial to Enroll Approximately 100 Patients Hospitalized With Covid-19.
Arca Biopharma Inc - Study Topline Data Anticipated Q2 2021.